Technical Analysis for PRPH - ProPhase Labs, Inc.

Grade Last Price % Change Price Change
grade D 3.01 3.44% 0.10
PRPH closed up 3.44 percent on Tuesday, January 15, 2019, on 86 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical PRPH trend table...

Date Alert Name Type % Chg
Jan 15 50 DMA Resistance Bearish 0.00%
Jan 15 MACD Bearish Centerline Cross Bearish 0.00%
Jan 15 Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Jan 15 Calm After Storm Range Contraction 0.00%
Jan 15 NR7 Range Contraction 0.00%
Jan 15 Inside Day Range Contraction 0.00%
Jan 15 Oversold Stochastic Weakness 0.00%
Jan 14 200 DMA Resistance Bearish 3.44%
Jan 14 20 DMA Resistance Bearish 3.44%
Jan 14 50 DMA Resistance Bearish 3.44%

Older signals for PRPH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

ProPhase Labs, Inc. engages in the manufacture, marketing, and distribution of homeopathic and health products to the general public. It is also involved in the research and development of over-the-counter (OTC) drugs, natural base health products with supplements, personal care, and cosmeceutical products. The company offers Cold-EEZE, a zinc gluconate glycine lozenge to reduce the duration and severity of the common cold symptoms. It also markets and distributes two non-lozenge forms of its proprietary zinc gluconate formulation, Cold-EEZE daytime/nighttime QuickMelts and Cold-EEZE oral spray; and Kids-EEZE products for children suffering from upper respiratory infections, allergy, and/or chest congestion, as well as organic cough drops and a Vitamin C supplements. It also provides private label lozenge products for retail customers; and performs contract manufacturing services of cough drop and other OTC cold remedy products for third parties. ProPhase Labs, Inc. sells its products through food, multi-outlet pharmacy and chain drug stores, wholesalers, and mass merchandisers in the United States. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.
Is PRPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 6.64
52 Week Low 2.25
Average Volume 7,219
200-Day Moving Average 3.128
50-Day Moving Average 3.1062
20-Day Moving Average 3.1885
10-Day Moving Average 3.2475
Average True Range 0.1929
ADX 19.27
+DI 32.8271
-DI 23.1564
Chandelier Exit (Long, 3 ATRs ) 3.4213
Chandelier Exit (Short, 3 ATRs ) 3.4887
Upper Bollinger Band 3.54
Lower Bollinger Band 2.837
Percent B (%b) 0.25
BandWidth 22.047985
MACD Line -0.0035
MACD Signal Line 0.0399
MACD Histogram -0.0433
Fundamentals Value
Market Cap 48.65 Million
Num Shares 16.2 Million
EPS 2.40
Price-to-Earnings (P/E) Ratio 1.25
Price-to-Sales 1.57
Price-to-Book 0.73
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.18
Resistance 3 (R3) 3.19 3.15 3.15
Resistance 2 (R2) 3.15 3.11 3.14 3.14
Resistance 1 (R1) 3.08 3.08 3.06 3.07 3.13
Pivot Point 3.04 3.04 3.03 3.03 3.04
Support 1 (S1) 2.97 3.00 2.95 2.96 2.89
Support 2 (S2) 2.93 2.97 2.92 2.88
Support 3 (S3) 2.86 2.93 2.87
Support 4 (S4) 2.85